Cited by 2,353HIV Research and TreatmentHIV/AIDS drug development and treatmentInfectious Diseases and Tuberculosis

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Open access

Heaton, R.K., Clifford, D.B., Franklin, D.R., Woods, S.P., Ake, C., Vaida, F., Ellis, R.J., Letendre, S.L., Marcotte, T.D., Atkinson, J.H., Rivera-Mindt, M., Vigil, O.R., Taylor, M.J., Collier, A.C., Marra, C.M., Gelman, B.B., McArthur, J.C., Morgello, S., Simpson, D.M., McCutchan, J.A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T.L., Wong, J., Grant, I., For the CHARTER Group·2010·Neurology

DOI 10.1212/wnl.0b013e318200d727PMC PMC2995535

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This is a cross-sectional, observational study to determine the frequency and associated features of HIV-associated neurocognitive disorders (HAND) in a large, diverse sample of infected individuals in the era of combination antiretroviral therapy (CART). METHODS: A total of 1,555 HIV-infected adults were recruited from 6 university clinics across the United States, with minimal exclusions. We used standardized neuromedical, psychiatric, and neuropsychological (NP) examinations, and recently published criteria for diagnosing HAND and classifying 3 levels of comorbidity (minimal to severe non-HIV risks for NP impairment). RESULTS: Fifty-two percent of the total sample had NP impairment, with higher rates in groups with greater comorbidity burden (40%, 59%, and 83%). Prevalence estimates for specific HAND diagnoses (excluding severely confounded cases) were 33% for asymptomatic neurocognitive impairment, 12% for mild neurocognitive disorder, and only 2% for HIV-associated dementia (HAD). Among participants with minimal comorbidities (n = 843), history of low nadir CD4 was a strong predictor of impairment, and the lowest impairment rate on CART occurred in the subset with suppressed plasma viral loads and nadir CD4 ≥200 cells/mm(3) (30% vs 47% in remaining subgroups). CONCLUSIONS: The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities. Future studies should clarify whether early disease events (e.g., profound CD4 decline) may trigger chronic CNS changes, and whether early CART prevents or reverses these changes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e318200d727

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Beck Depression Inventory–II
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Updated research nosology for HIV-associated neurocognitive disorders
Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000287431.88658.8b · Cited by 2,630
Self-citation
Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
Letendre, S. L. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.31 · Cited by 831
Self-citation
The impact of HIV-associated neuropsychological impairment on everyday functioning
Heaton, R. K., Marcotte, T. D., Mindt, M. R., Sadek, J. R., Moore, D. J., Bentley, H. A., McCutchan, J. A., REICKS, C., Grant, I., & THE HNRC GROUP (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704102130 · Cited by 726
Self-citation
The HNRC 500-Neuropsychology of Hiv infection at different disease stages
Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M. J., Kelly, M. D., Ellis, R. J., et al. (1995) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700000230 · Cited by 636
Self-citation
HIV and antiretroviral therapy in the brain: neuronal injury and repair
Ellis, R. J., Langford, D., & Masliah, E. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn2040 · Cited by 533
Self-citation
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
Cartier, L., Hartley, O., Dubois‐Dauphin, M., & Krause, K. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 520
Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Comandini, U. V., Vlassi, C., Giulianelli, M., Galgani, S., Antinori, A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318042e1ee · Cited by 323
Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome
Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A. E., Heaton, R. K., Wallace, M. R., ABRAMSON, I. S., Atkinson, J. H., Grant, I., & McCutchan, J. A. (1997) · Annals of Neurology · doi:10.1002/ana.410420503 · Cited by 318
Self-citation
Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV
Woods, S. P., Rippeth, J. D., Frol, A. B., Levy, J. K., Ryan, E., Soukup, V. M., Hinkin, C. H., Lazzaretto, D., Cherner, M., Marcotte, T. D., et al. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490509565 · Cited by 311
Self-citation

Show all 33 references

Sorted by citations

Items 601–700 of 1,002

Utility of the Montreal Cognitive Assessment (MoCA) and its subset in HIV-associated neurocognitive disorder (HAND) screening
Kim, W. J., Ku, N. S., Lee, Y., Ahn, J. Y., Kim, S. B., Ahn, H.-W., Hong, K., Song, J. Y., Cheong, H. J., Kim, W. J., et al. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.11.006 · Cited by 34
Immune activation and neuroinflammation in alcohol use and HIV infection: evidence for shared mechanisms
Monnig, M. A. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1211667 · Cited by 35
Real-World Impact of HIV-Associated Neurocognitive Impairment
Casaletto, K. B., Weber, E., Iudicello, J. E., & Woods, S. P. (2016) · Springer eBooks · doi:10.1007/978-0-387-98188-8_10 · Cited by 34
Self-citation
Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic
Marin-Webb, V., Jessen, H. K., Kopp, U. A., Jessen, A. B., & Hahn, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168225 · Cited by 34
Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV
Laverick, R., Haddow, L. J., Daskalopoulou, M., Lampe, F. C., Gilson, R. J. C., Speakman, A., Antinori, A., Bruun, T., Vassilenko, A., Collins, S., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001468 · Cited by 34
Self-citation
Nucleoside reverse transcriptase inhibitors (NRTIs) induce proinflammatory cytokines in the CNS via Wnt5a signaling
Wu, T., Zhang, J., Geng, M., Tang, S., Zhang, W., & Shu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03446-w · Cited by 34
Assessment and Management of HIV-Associated Cognitive Impairment: Experience from a Multidisciplinary Memory Service for People Living with HIV
Alford, K. A., Banerjee, S., Nixon, E., O’Brien, C., Pounds, O., Butler, A., Elphick, C., Henshaw, P., Anderson, S., & Vera, J. H. (2019) · Brain Sciences · doi:10.3390/brainsci9020037 · Cited by 34
Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control study
Petersen, K. J., Lu, T., Wisch, J. K., Roman, J., Metcalf, N. V., Cooley, S., Babulal, G. M., Paul, R., Sotiras, A., Vaida, F., et al. (2023) · The Lancet HIV · doi:10.1016/s2352-3018(22)00373-3 · Cited by 33
Self-citation
The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals
Baker, L. M., Paul, R. H., Heaps‐Woodruff, J. M., Chang, J. Y., Ortega, M., Margolin, Z. R., Usher, C., Basco, B., Cooley, S., & Ances, B. M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9610-4 · Cited by 33
A history of alcohol dependence augments HIV-associated neurocognitive deficits in persons aged 60 and older
Gongvatana, A., Morgan, E. E., Iudicello, J. E., Letendre, S. L., Grant, I., & Woods, S. P. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0277-z · Cited by 33
Self-citation
Validity of the International HIV Dementia Scale in Brazil
Rodrigues, R. A., Oliveira, R. L., Grinsztejn, B. G. J., & Silva, M. T. T. (2013) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130042 · Cited by 33
Protease inhibitor monotherapy and the CNS: peace of mind?
Valero, I., Bayón, C., Cambron, I., González, A., & Arribas, J. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr229 · Cited by 33
Identification of an Abbreviated Test Battery for Detection of HIV-Associated Neurocognitive Impairment in an Early-Managed HIV-Infected Cohort
Moore, D. J., Roediger, M. P., Eberly, L. E., Blackstone, K., Hale, B., Weintrob, A., Ganesan, A., Agan, B. K., Letendre, S. L., & Crum‐Cianflone, N. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047310 · Cited by 33
Self-citation
Clinical utility of the UCSD Performance-Based Skills Assessment—Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties
Moore, R. C., Paolillo, E. W., Heaton, A., Fazeli, P. L., Jeste, D. V., & Moore, D. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183614 · Cited by 33
Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals
Stauch, K. L., Emanuel, K. M., Lamberty, B. G., Morsey, B., & Fox, H. S. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0573-5 · Cited by 33
The alpha7-nicotinic receptor contributes to gp120-induced neurotoxicity: implications in HIV-associated neurocognitive disorders
Capó-Vélez, C. M., Morales‐Vargas, B., García-González, A. P., Grajales‐Reyes, J. G., Delgado‐Vélez, M., Madera, B., Báez-Pagán, C. A., Quesada, O., & Lasalde‐Dominicci, J. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-20271-x · Cited by 33
HIV‐1 Tat promotes astrocytic release of CCL2 through MMP/PAR‐1 signaling
Bozzelli, P. L., Yin, T., Avdoshina, V., Mocchetti, I., Conant, K. E., & Maguire‐Zeiss, K. A. (2019) · Glia · doi:10.1002/glia.23642 · Cited by 33
Dancing with Trojan horses: an interplay between the extracellular vesicles and viruses
Badierah, R., Uversky, V. N., & Redwan, E. M. M. M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1756409 · Cited by 34
HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders
Cheney, L., Guzik, H. M., Macaluso, F., Macián, F., Cuervo, A. M., & Berman, J. W. (2020) · Cells · doi:10.3390/cells9061426 · Cited by 34
Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging
Lew, B. J., Schantell, M. D., O’Neill, J., Morsey, B., Wang, T., Ideker, T., Swindells, S., Fox, H. S., & Wilson, T. W. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab045 · Cited by 33
Cannabis and Inflammation in HIV: A Review of Human and Animal Studies
Ellis, R. J., Wilson, N., & Peterson, S. N. (2021) · Viruses · doi:10.3390/v13081521 · Cited by 33
Self-citation
Markers of Gut Barrier Function and Microbial Translocation Associate with Lower Gut Microbial Diversity in People with HIV
Ellis, R. J., Iudicello, J. E., Heaton, R. K., Isnard, S., Lin, J. C.-Y., Routy, J., Gianella, S., Hoenigl, M., & Knight, R. D. (2021) · Viruses · doi:10.3390/v13101891 · Cited by 33
Self-citation
Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses
Gumbs, S. B. H., Kübler, R., Gharu, L., Schipper, P. J., Borst, A. L., Snijders, G. J. L., Ormel, P. R., van Berlekom, A. B., Wensing, A. M. J., de Witte, L. D., et al. (2022) · Journal of NeuroVirology · doi:10.1007/s13365-021-01049-w · Cited by 34
HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study
Luma, H. N., Tchaleu, B. C. N., Temfack, E., Doualla, M. S., Ndenga, D. P. N., Mapoure, Y. N., NJAMNSHI, A. K., & Djientcheu, V. (2013) · AIDS Research and Treatment · doi:10.1155/2013/709810 · Cited by 33
Management issues in HIV-associated neurocognitive disorders
Cysique, L. A., Bain, Lanĕ, & Brew, B. J. (2012) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s30466 · Cited by 34
Genome‐wide association study of neurocognitive impairment and dementia in HIV‐infected adults
Levine, A. J., Service, S. K., Miller, E. N., Reynolds, S. M., Singer, E. J., Shapshak, P., Martin, E. M., Sacktor, N. C., Becker, J. T., Jacobson, L. P., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32071 · Cited by 33
Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus
Bogoch, I. I., Davis, B. T., & Venna, N. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.011 · Cited by 33
Cognitive Dysfunction among HIV Positive and HIV Negative Patients with Psychosis in Uganda
Nakasujja, N., Allebeck, P., Agren, H., Musisi, S., & Katabira, E. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044415 · Cited by 33
Effects of smoking and alcohol use on neurocognitive functioning in heavy drinking, HIV-positive men who have sex with men
Monnig, M. A., Kahler, C. W., Lee, H., Pantalone, D. W., Mayer, K. H., Cohen, R. A., & Monti, P. M. (2015) · AIDS Care · doi:10.1080/09540121.2015.1093595 · Cited by 33
Learning and Memory in Children and Adolescents With Perinatal HIV Infection and Perinatal HIV Exposure
Nichols, S., Chernoff, M. C., Malee, K., Sirois, P. A., Williams, P. L., Figueroa, V., & Woods, S. P. (2016) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001131 · Cited by 33
Self-citation
Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain
Hahn, Y. K., Paris, J. J., Lichtman, A. H., Hauser, K. F., Sim‐Selley, L. J., Selley, D. E., & Knapp, P. E. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.014 · Cited by 34
Falls among Middle-Aged Women in the Women's Interagency HIV Study
Sharma, A., Hoover, D. R., Shi, Q., Holman, S., Plankey, M. W., Wheeler, A. L., Weber, K. M., Floris-Moore, M., Bolívar, H., Vance, D. E., et al. (2015) · Antiviral Therapy · doi:10.3851/imp3070 · Cited by 33
Association between cognitive reserve and cognitive performance in people with HIV: a systematic review and meta-analysis
Kaur, N., Dendukuri, N., Fellows, L. K., Brouillette, M., & Mayo, N. E. (2019) · AIDS Care · doi:10.1080/09540121.2019.1612017 · Cited by 33
Virologically suppressed patients with asymptomatic and symptomatic HIV ‐associated neurocognitive disorders do not display the same pattern of immune activation
Vassallo, M., Durant, J., Lebrun‐Frénay, C., Fabre, R., Ticchioni, M., Andersen, S., DeSalvador, F., Harvey-Langton, A., Dunais, B., Cohen-Codar, I., et al. (2015) · HIV Medicine · doi:10.1111/hiv.12246 · Cited by 32
Multiple Protein Kinases via Activation of Transcription Factors NF-κB, AP-1 and C/EBP-δ Regulate the IL-6/IL-8 Production by HIV-1 Vpr in Astrocytes
Gangwani, M. R., & Kumar, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135633 · Cited by 32
Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection
Hulgan, T., Samuels, D. C., Bush, W. S., Ellis, R. J., Letendre, S. L., Heaton, R. K., Franklin, D. R., Straub, P., Murdock, D. G., Clifford, D. B., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ527 · Cited by 32
Self-citation
Preliminary Findings Describing Participant Experience With iSTEP, an mHealth Intervention to Increase Physical Activity and Improve Neurocognitive Function in People Living With HIV
Henry, B. L., & Moore, D. J. (2016) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2016.01.001 · Cited by 32
Humanized mice: models for evaluating NeuroHIV and cure strategies
Honeycutt, J. B., & García, J. V. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0567-3 · Cited by 32
Sex-based differences in neurocognitive functioning in HIV-infected young adults
Burlacu, R., Umlauf, A., Luca, A. E., Gianella, S., Rădoi, R., Ruță, S. M., Marcotte, T. D., Ene, L., & Achim, C. L. (2017) · AIDS · doi:10.1097/qad.0000000000001687 · Cited by 32
Self-citation
Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions
Tiwari, S., Atluri, V. S. R., Yndart, A., Jayant, R. D., Kaushik, A. K., Geiger, J. D., & Nair, M. N. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00291 · Cited by 32
Molecular Imaging of Neuroinflammation in HIV
Boerwinkle, A. H., & Ances, B. M. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9823-4 · Cited by 33
Altered neuropsychological performance and reduced brain volumetrics in people living with HIV on integrase strand transfer inhibitors
O’Halloran, J. A., Cooley, S., Strain, J. F., Boerwinkle, A. H., Paul, R. H., Presti, R. M., & Ances, B. M. (2019) · AIDS · doi:10.1097/qad.0000000000002236 · Cited by 32
Neurocognitive Phenotyping of HIV in the Era of Antiretroviral Therapy
Paul, R. H. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00426-9 · Cited by 32
Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis
Gao, C., Meng, J., Xiao, X., Wang, M., Williams, A. B., & Wang, H. (2020) · International Journal of Nursing Sciences · doi:10.1016/j.ijnss.2020.03.007 · Cited by 32
Mitochondrial DNA Damage and Brain Aging in Human Immunodeficiency Virus
Roca-Bayerri, C., Robertson, F. M., Pyle, A., Hudson, G., & Payne, B. A. I. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa984 · Cited by 32
Providing differentiated service delivery to the ageing population of people living with HIV
Godfrey, C. C., Vallabhaneni, S., Shah, M. P., & Grimsrud, A. (2022) · Journal of the International AIDS Society · doi:10.1002/jia2.26002 · Cited by 32
Ketone bodies protection against HIV‐1 Tat‐induced neurotoxicity
Liang, H., Chen, X., Bhatt, D. P., Geiger, N. H., Rosenberger, T. A., Haughey, N. J., Masino, S. A., & Geiger, J. D. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07764.x · Cited by 32
Concurrent Validity of a Computer-Based Cognitive Screening Tool for Use in Adults with HIV Disease
Becker, J. T., Dew, M. A., Aizenstein, H. J., López, O. L., Morrow, L. A., & Saxton, J. A. (2011) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0051 · Cited by 32
Decreased MEG beta oscillations in HIV-infected older adults during the resting state
Becker, K. M., Heinrichs‐Graham, E., Fox, H. S., Robertson, K. R., Sandkovsky, U., O’Neill, J., Swindells, S., & Wilson, T. W. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0220-8 · Cited by 32
Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa
Goodkin, K., Hardy, D. J., Singh, D. K., & López, E. (2014) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.13080178 · Cited by 32
Approaches to Identifying Appropriate Medication Adherence Assessments for HIV Infected Individuals with Comorbid Bipolar Disorder
Badiee, J., Riggs, P. K., Rooney, A. S., Vaida, F., Grant, I., Atkinson, J. H., & Moore, D. J. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0447 · Cited by 32
Self-citation
Apathy is associated with lower mental and physical quality of life in persons infected with HIV
Kamat, R., Woods, S. P., Cameron, M. V., Iudicello, J. E., & The HIV Neurobehavioral Research Program (HNRP) Group (2016) · Psychology Health & Medicine · doi:10.1080/13548506.2015.1131998 · Cited by 32
Self-citation
Prevalence and correlates for ADHD and relation with social and academic functioning among children and adolescents with HIV/AIDS in Uganda
Mpango, R. S., Kinyanda, E., Rukundo, G. Z., Levin, J. B., Gadow, K. D., & Patel, V. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1488-7 · Cited by 32
Axonal chronic injury in treatment-naïve HIV+ adults with asymptomatic neurocognitive impairment and its relationship with clinical variables and cognitive status
Li, R., Sun, J., Tang, Z., Jing-ji, Z., & Li, H.-J. (2018) · BMC Neurology · doi:10.1186/s12883-018-1069-5 · Cited by 32
Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease
Saloner, R., Cherner, M., Grelotti, D. J., Paolillo, E. W., Moore, D. J., Heaton, R. K., Letendre, S. L., Kumar, A. M., Grant, I., & Ellis, R. J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.012 · Cited by 32
Self-citation
Caspase cleavage of gasdermin E causes neuronal pyroptosis in HIV-associated neurocognitive disorder
Fernandes, J. P., Branton, W. G., Cohen, É. A., Koopman, G., Kondova, I. I., Gelman, B. B., & Power, C. (2023) · Brain · doi:10.1093/brain/awad375 · Cited by 31
Self-citation
Neurologic Complications in Treated HIV-1 Infection
Bhatia, N. S., & Chow, F. C. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0666-1 · Cited by 31
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals
Anderson, A. M. L., Lennox, J. L., Mulligan, M. M., Loring, D. W., Zetterberg, H., Blennow, K., Kessing, C. F., Koneru, R., Easley, K. A., & Tyor, W. R. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0466-z · Cited by 31
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining “symptomatic” versus “asymptomatic” HAND
Obermeit, L. C., Beltran, J., Casaletto, K. B., Franklin, D. R., Letendre, S. L., Ellis, R. J., Fennema‐Notestine, C., Vaida, F., Collier, A. C., Marra, C. M., et al. (2016) · Journal of NeuroVirology · doi:10.1007/s13365-016-0474-z · Cited by 31
Self-citation
Discordant CSF/plasma HIV-1 RNA in individuals on virologically suppressive antiretroviral therapy in Western India
Dravid, A. N., Natrajan, K., Kulkarni, M. M., Saraf, C. K., Mahajan, U. S., Kore, S. D., Rathod, N. M., Mahajan, U. S., & Wadia, R. S. (2018) · Medicine · doi:10.1097/md.0000000000009969 · Cited by 31
Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy
Montoya, J. L., Campbell, L. M., Paolillo, E. W., Ellis, R. J., Letendre, S. L., Jeste, D. V., & Moore, D. J. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001881 · Cited by 34
Self-citation
Altered intrinsic local activity and cognitive dysfunction in HIV patients: A resting-state fMRI study
Bak, Y., Jun, S., Choi, J. Y., Lee, Y., Lee, S., Han, S. H., & Shin, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207146 · Cited by 31
Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review
Nyamayaro, P. C., Chibanda, D., Robbins, R. N., Hakim, J. G., & Gouse, H. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2019.1606284 · Cited by 31
Frailty in medically complex individuals with chronic HIV
Morgello, S., Gensler, G. R., Sherman, S. J., Ellis, R. J., Gelman, B. B., Kolson, D. L., Letendre, S. L., Robinson‐Papp, J., Rubin, L. H., Singer, E. J., et al. (2019) · AIDS · doi:10.1097/qad.0000000000002250 · Cited by 31
Self-citation
The Neurocognitive Assessment in the Metabolic and Aging Cohort ( NAMACO ) study: baseline participant profile
Métral, M., Darling, K., Locatelli, I., Nadin, I., Santos, G., Brugger, P., Kovari, H., Cusini, A., Gutbrod, K., TARR, P. E., et al. (2019) · HIV Medicine · doi:10.1111/hiv.12795 · Cited by 31
Smartphone-Based Measurement of Executive Function in Older Adults with and without HIV
Moore, R. C., Campbell, L. M., Delgadillo, J. D., Paolillo, E. W., Sundermann, E. E., Holden, J. L., Schweitzer, P., Heaton, R. K., & Swendsen, J. D. (2019) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acz084 · Cited by 31
Self-citation
Objective and subjective sleep measures are associated with neurocognition in aging adults with and without HIV
Campbell, L. M., Kohli, M., Lee, E., Kaufmann, C. N., Higgins, M., Delgadillo, J. D., Heaton, R. K., Cherner, M., Ellis, R. J., Moore, D. J., et al. (2020) · The Clinical Neuropsychologist · doi:10.1080/13854046.2020.1824280 · Cited by 33
Self-citation
The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG study
Arif, Y., Wiesman, A. I., O’Neill, J., Embury, C. M., May, P. E., Lew, B. J., Schantell, M. D., Fox, H. S., Swindells, S., & Wilson, T. W. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103065 · Cited by 31
Increased incidence of dementia following herpesvirus infection in the Korean population
Shim, Y., Park, M., & Kim, J. (2022) · Medicine · doi:10.1097/md.0000000000031116 · Cited by 31
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency Virus
Letendre, S. L., Chen, H., McKhann, A., Roa, J., Vecchio, A., Daar, E. S., Berzins, B., Hunt, P. W., Marra, C. M., Campbell, T., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad265 · Cited by 31
Self-citation
Abnormal MEG Oscillatory Activity during Visual Processing in the Prefrontal Cortices and Frontal Eye-Fields of the Aging HIV Brain
Wilson, T. W., Fox, H. S., Robertson, K. R., Sandkovsky, U., O’Neill, J., Heinrichs‐Graham, E., Knott, N. L., & Swindells, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066241 · Cited by 31
A systematic review examining whether interventions are effective in reducing cognitive delay in children infected and affected with HIV
Sherr, L., Croome, N., Bradshaw, K., & Castaneda, K. P. (2014) · AIDS Care · doi:10.1080/09540121.2014.906560 · Cited by 31
HIV-1 Glycoprotein 120 Enhancement of N-Methyl-D-Aspartate NMDA Receptor-Mediated Excitatory Postsynaptic Currents: Implications for HIV-1-Associated Neural Injury
Zhou, Y., Liu, J., & Xiong, H. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9719-0 · Cited by 31
HIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs
Cohen, J., D’Agostino, L., Tüzer, F., & Torres, C. A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.008 · Cited by 31
Neurologic Complications of Human Immunodeficiency Virus Infection
Saylor, D. R. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000647 · Cited by 31
Modeling HIV-1 infection and NeuroHIV in hiPSCs-derived cerebral organoid cultures
Donadoni, M., Çakır, S., Bellizzi, A., Swingler, M., & Sariyer, I. K. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01204-z · Cited by 30
A Brief and Feasible Paper-Based Method to Screen for Neurocognitive Impairment in HIV-Infected Patients
Muñoz-Moreno, J. A., Prats, A., Pérez‐Álvarez, N., Fumaz, C. R., Garolera, M., Doval, E., Negredo, E., Ferrer, M. J., & Clotet, B. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31829e1408 · Cited by 30
Understanding the MIND phenotype: macrophage/microglia inflammation in neurocognitive disorders related to human immunodeficiency virus infection
Brown, A. M. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0049-2 · Cited by 31
Neurologic Complications of Human Immunodeficiency Virus Infection
Nath, A. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000244 · Cited by 30
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders
Liu, H., Xu, E., Liu, J., & Xiong, H. (2016) · Brain Sciences · doi:10.3390/brainsci6030023 · Cited by 30
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition
Latronico, T., Pati, I., Ciavarella, R., Fasano, A., Mengoni, F., Lichtner, M., Vullo, V., Mastroianni, C. M., & Liuzzi, G. M. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14269 · Cited by 30
Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.
Anderson, A., Jones, J. D., Thaler, N. S., Kuhn, T. P., Singer, E. J., & Hinkin, C. H. (2018) · Neuropsychology · doi:10.1037/neu0000482 · Cited by 30
Adult neurogenic deficits in HIV-1 Tg26 transgenic mice
Putatunda, R., Zhang, Y., Li, F., Yang, X., Barbe, M. F., & Hu, W. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1322-2 · Cited by 31
Neurocognitive Impairment in Well-Controlled HIV-Infected Patients: A Cross-Sectional Study
Portilla, I., Reus, S., León, R., Hofstadt, C. V.-D., Sánchez, J., López, N., Boix, V., Merino, E., & Portilla, J. (2019) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0279 · Cited by 31
Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus–Infected Patients
Dastgheyb, R. M., Sacktor, N. C., Franklin, D. R., Letendre, S. L., Marcotte, T. D., Heaton, R. K., Grant, I., McArthur, J. C., Rubin, L. H., & Haughey, N. J. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002093 · Cited by 30
Self-citation
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs
Benedetto, I. D., Trunfio, M., Guastamacchia, G., Bonora, S., & Calcagno, A. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00874-9 · Cited by 30
Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period
Rourke, S. B., Bekele, T., Rachlis, A., Kovacs, C. M., Brunetta, J. M., Gill, M. J., Carvalhal, A., Cysique, L. A., Marcotte, T. D., & Power, C. (2020) · AIDS · doi:10.1097/qad.0000000000002709 · Cited by 30
Self-citation
The neurological sequelae of pandemics and epidemics
Valério, F., Whitehouse, D. P., Menon, D. K., & Newcombe, V. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10261-3 · Cited by 30
Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure
Alamer, E., Zhong, C., Hajnik, R. L., Soong, L., & Hu, H. (2021) · Retrovirology · doi:10.1186/s12977-020-00547-9 · Cited by 32
Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
Weiss, J. J., Calvi, R. M., Naganawa, M., Toyonaga, T., Farhadian, S., Chintanaphol, M., Chiarella, J., Zheng, M., Ropchan, J. R., Huang, Y. H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab484 · Cited by 32
HIV-1 persistence in the CNS: Mechanisms of latency, pathogenesis and an update on eradication strategies
Sonti, S., Sharma, A. L., & Tyagi, M. (2021) · Virus Research · doi:10.1016/j.virusres.2021.198523 · Cited by 31
Machine Learning Approaches to Understand Cognitive Phenotypes in People With HIV
Mukerji, S. S., Petersen, K. J., Pohl, K. M., Dastgheyb, R. M., Fox, H. S., Bilder, R. M., Brouillette, M., Gross, A. L., Scott‐Sheldon, L. A. J., Paul, R. H., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac293 · Cited by 30
The relationship between HIV‐1 neuroinflammation, neurocognitive impairment and encephalitis pathology: A systematic review of studies investigating post‐mortem brain tissue
Williams, M. E., & Naudé, P. J. W. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2519 · Cited by 31
The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future
Cysique, L. A., Bain, M. P., Brew, B. J., & Murray, J. M. (2011) · Sexual Health · doi:10.1071/sh11003 · Cited by 30
Neurocognitive functioning in a Romanian cohort of young adults with parenterally-acquired HIV-infection during childhood
Ene, L., Franklin, D. R., Burlacu, R., Luca, A. E., Blaglosov, A. G., Ellis, R. J., Alexander, T. J., Umlauf, A., Grant, I., Duiculescu, D., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0275-1 · Cited by 30
Self-citation
Altered Functional Response to Risky Choice in HIV Infection
Connolly, C. G., Bischoff‐Grethe, A., Jordan, S. J., Woods, S. P., Ellis, R. J., Paulus, M. P., & Grant, I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111583 · Cited by 30
Self-citation
Astrocytic expression of HIV-1 viral protein R in the hippocampus causes chromatolysis, synaptic loss and memory impairment
Torres, L., & Noel, R. J. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-53 · Cited by 30
Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy
Gill, A. J., Kovacsics, C. E., Vance, P. J., Collman, R. G., & Kolson, D. L. (2015) · Journal of Virology · doi:10.1128/jvi.01495-15 · Cited by 30
The Impact of Marijuana Use on Memory in HIV-Infected Patients: A Comprehensive Review of the HIV and Marijuana Literatures
Skalski, L. M., Towe, S. L., Sikkema, K. J., & Meade, C. S. (2017) · Current Drug Abuse Reviews · doi:10.2174/1874473709666160502124503 · Cited by 30
Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders
Hung, K.-M., Chen, P., Hsieh, H.-C., & Calkins, M. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.017 · Cited by 32

Authors: Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., McCutchan, J. A., Abramson, I., Gamst, A., Fennema-Notestine, C., Jernigan, T. L., Wong, J., Grant, I., & For the CHARTER Group
Affiliations: University of California San Diego (US)
From the University of California (R.K.H., D.R.F., S.P.W., C.A., F.V., R.J.E., S.L.L., T.D.M., J.H.A., O.R.V., M.J.T., J.A.M., I.A., A.G., C.F.-N., T.L.J., I.G.), San Diego; University of California (J.W.), San Francisco; Washington University (D.B.C.), St. Louis, MO; Mount Sinai School of Medicine (M.R.-M., S.M., D.M.S.), New York, NY; University of Washington (A.C.C., C.M.M.), Seattle; University of Texas Medical Branch (B.B.G.), Galveston; and Johns Hopkins University (J.C.M.), Baltimore, MD.
ORCID: Heaton, R.K.
Clifford, D.B.
Franklin, D.R.
Woods, S.P.
Vaida, F.
Ellis, R.J.
Letendre, S.L.
Marcotte, T.D.
Taylor, M.J.
Collier, A.C.
Marra, C.M.
McArthur, J.C.
Morgello, S.
Simpson, D.M.
McCutchan, J.A.
Jernigan, T.L.
Venue: Neurology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2010-12-07
Volume: 75
Issue: 23
Pages: 2087-2096
ISSN: 0028-3878 (ISSN-L)
1526-632X
DOI: 10.1212/wnl.0b013e318200d727
PMC: PMC2995535
OpenAlex: W2137321682
Cited by: 2,353
References: 33
Citations by year: 2026: 92 · 2025: 93 · 2024: 119 · 2023: 131 · 2022: 127 · 2021: 182 · 2020: 172 · 2019: 225 · 2018: 153 · 2017: 202 · 2016: 181 · 2015: 172 · 2014: 165 · 2013: 152 · 2012: 115
FWCI: 38.09
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Neurology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Fordham Research Commons (Fordham University) (submittedVersion)
Funders: National Institutes of Health (5u01ai069495-05, n01mh22005-16-0-1, 5r01ag024506-03, 5r01ns036524-10, N01 MH22005, MH22005)
Centers for Disease Control and Prevention (U2G PS00623)
U.S. Public Health Service (R213857-53187, NIMH-22005)
National Institute on Alcohol Abuse and Alcoholism (R01 AA13419, R01AA013419, R32AA17321)
National Institute on Aging (R01AG015301, U01‐AG10483, R01AG031224, R01-AG024506, R01 AG-15301, U01AG010483, R01AG022381, U19AG010483)
National Heart, Lung, and Blood Institute (R01HL084229, R01 HL95089, R01 HL84229, R01HL095089)
National Institute of Mental Health (U01MH083507, U01-MH83506, R21-MH85610, R01MH067831, U01MH083506, R01-MH73419, N01 MH-22005, R01 MH73433, R01MH079881, N01 MH22005-08, R01 MH-60720, R01 MH78748, R01MH058076, R21MH78728, MH 22005, N01MH022005, R01MH064907, K23MH079718, R01MH081861, MH058076, R01MH085608, R01 MH78737, R01MH64907, R01MH083552, R01MH073419, R24-MH-59724, U13 MH81676, R32 MH77487, R01MH079886, R24MH059724, R21MH078728, U01MH083501, R01MH38552, R01MH078737, R21MH085610, R01 MH81861, R01 MH83552, R01 MH79752, R01MH078748, R01MH073433, R01MH079752, R01MH060720, P30MH62512, R01MH061146, MH085608-01, MH083506-02, R01 MH61146, R01 MH79881, R01 MH075673, R21MH083573, R01MH084796, MH083552-02, P30MH062512, U13MH081676, R01 MH58076)
National Institute on Drug Abuse (P50DA026306, R01 DA21115, RC2DA029475, DA026306-01, P01DA012065, P50DA26306, RC2-DA29475, P01-DA12065, DA012065-10, DA026146, P01DA026146, R03DA022137, R01DA021115)
National Institute of Allergy and Infectious Diseases (AI 27757, R01-AI47033, AI-069434, AI069918, UO1AI69495, U01 AI74521, U01AI074521, R01AI034235, U01AI069432, R01AI047033, 00-AI-0005, U01 AI69432, R01AI087145, P01AI057005, AI069438, AI068543, 1R01 NS/AI34235, P30AI027757, U01AI069918)
National Institute of Neurological Disorders and Stroke (R01 NS44807, R21NS069355, R01NS049465, UO1 NS32228, R01NS044807, R01NS49465, RC1NS068904, R01-NS-41198, R01NS041198, R01-NS36524, R01NS051132, U01NS032228)
National Center for Research Resources (U24RR021992, U24RR021382, K30RR22681, K30RR022681, U24 RR21382, U24RR019701)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
Keywords: HIV-associated neurocognitive disorders, HIV-associated dementia, highly active antiretroviral therapy, CD4 nadir, viral suppression, comorbidities, asymptomatic neurocognitive impairment, mild neurocognitive disorder, HIV infection
MeSH terms: Activities of Daily Living, Adult, Algorithms, Cognition Disorders, Disability Evaluation, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Neurologic Examination, Neuropsychological Tests, Psychiatric Status Rating Scales, Retrospective Studies, Models, Statistical, HIV Infections, Cross-Over Studies, Observation, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks